IOMEDICO AG

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer

First Posted Date
2015-04-07
Last Posted Date
2020-09-10
Lead Sponsor
iOMEDICO AG
Target Recruit Count
500
Registration Number
NCT02410044
Locations
🇩🇪

Multiple sites all over Germany, Multiple Locations, Germany

Bone Pain Score Validation Initiative

Completed
Conditions
First Posted Date
2014-11-18
Last Posted Date
2018-08-10
Lead Sponsor
iOMEDICO AG
Target Recruit Count
370
Registration Number
NCT02293642
Locations
🇩🇪

Multiple Sites All Over Germany, Multiple Locations, Germany

Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab

First Posted Date
2014-09-25
Last Posted Date
2017-11-13
Lead Sponsor
iOMEDICO AG
Target Recruit Count
85
Registration Number
NCT02248571
Locations
🇩🇪

iOMEDICO AG, Freiburg, Baden-Wuerttemberg, Germany

Tumor Registry Pancreatic Cancer

Completed
Conditions
First Posted Date
2014-03-17
Last Posted Date
2024-10-14
Lead Sponsor
iOMEDICO AG
Target Recruit Count
2325
Registration Number
NCT02089269
Locations
🇩🇪

iOMEDICO, Freiburg, BW, Germany

Non-interventional Study With Pomalidomide (Imnovid®)

Completed
Conditions
First Posted Date
2014-03-03
Last Posted Date
2022-08-12
Lead Sponsor
iOMEDICO AG
Target Recruit Count
151
Registration Number
NCT02075996
Locations
🇩🇪

iOMEDICO AG, Freiburg, Baden-Wuerttemberg, Germany

Clinical Tumor Anemia Registry (TAR)

Completed
Conditions
First Posted Date
2013-02-21
Last Posted Date
2016-02-29
Lead Sponsor
iOMEDICO AG
Target Recruit Count
1018
Registration Number
NCT01795690
Locations
🇩🇪

iOMEDICO, Freiburg, Germany

Non-interventional Study With Nab-Paclitaxel (Abraxane®)

Completed
Conditions
First Posted Date
2012-09-21
Last Posted Date
2018-06-20
Lead Sponsor
iOMEDICO AG
Target Recruit Count
705
Registration Number
NCT01689610
Locations
🇩🇪

iOMEDICO AG, Freiburg, Baden-Wuerttemberg, Germany

First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma

First Posted Date
2012-01-31
Last Posted Date
2017-08-23
Lead Sponsor
iOMEDICO AG
Target Recruit Count
44
Registration Number
NCT01521715
Locations
🇩🇪

Urolog. Klinik im Waldkrankenhaus St. Marien, Friedrich-Alexander-Universität, Erlangen, Germany

🇩🇪

Universitätsklinikum Essen, Klinik f. Urologie, Essen, Germany

🇩🇪

Medizinisches Versorgungszentrum (MVZ) Osthessen GmbH, Fulda, Germany

and more 5 locations

Tumour Registry Breast Cancer

Completed
Conditions
First Posted Date
2011-05-11
Last Posted Date
2022-02-24
Lead Sponsor
iOMEDICO AG
Target Recruit Count
4500
Registration Number
NCT01351584

Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)

First Posted Date
2010-12-24
Last Posted Date
2017-11-14
Lead Sponsor
iOMEDICO AG
Target Recruit Count
64
Registration Number
NCT01266837
Locations
🇩🇪

Klinik für Innere Medizin (Tumorforschung), Universitätsklinikum Essen, Essen, Germany

🇩🇪

Urologie - Waldkrankenhaus St. Marien, Erlangen, Germany

🇩🇪

Klinik und Poliklinik für Urologie , Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Dresden, Germany

and more 5 locations
© Copyright 2024. All Rights Reserved by MedPath